Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ANVS
Recent news which mentions ANVS
< Previous
1
2
3
Next >
Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off
August 24, 2022
Tickers
ANVS
Tags
Movers & Shakers
Patient Enrollment
General
From
Benzinga
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
August 02, 2022
Tickers
ANVS
LGVN
LLY
TECH
Tags
Longeveron
LGVN
Market News
From
Benzinga
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4
July 07, 2022
Tickers
AMC
ANVS
GME
VIVO
Tags
AMC
Today's Market
NYSE:AMC,NASDAQ:VIVO,NYSE:ANVS,NYSE:GME
From
InvestorPlace
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
July 07, 2022
Tickers
ANVS
GME
Tags
Today's Market
NYSE:ANVS,NYSE:GME
GME
From
InvestorPlace
FDA Gives Green Signal To Annovis Bio's Parkinson's Trial With Buntanetap
July 07, 2022
Tickers
ANVS
Tags
Market News
News
Trading Ideas
From
Benzinga
Annovis Bio Gets FDA Nod For Late-Stage Parkinson Disease Study Amendments
July 07, 2022
Tickers
ANVS
Tags
Biotech
Benzinga
Health Care
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 07, 2022
Tickers
ACRX
ALNA
ANVS
AVRO
Tags
REVB
AVRO
TTNP
From
Benzinga
83 Biggest Movers From Yesterday
June 09, 2022
Tickers
ACLX
ADTH
AERC
AMLX
Tags
DBVT
VVPR
HCM
From
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
June 08, 2022
Tickers
ACLX
ACRX
AERC
ANVS
Tags
KPLT
OMEX
COSM
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
May 02, 2022
Tickers
ACCD
AJG
ANVS
ARTA
Tags
Upgrades
Intraday Update
KEY
From
Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
April 29, 2022
Tickers
ABBV
ALDX
ANVS
AZN
Tags
Biotech
Benzinga
BLTE
From
Benzinga
FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease
January 25, 2022
Tickers
ANVS
Tags
Movers
Biotech
Phase 3 Trial
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 27, 2021
Tickers
ABEO
ALRN
ANVS
ATHE
Tags
OPTN
RMTI
Movers
From
Benzinga
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
December 27, 2021
Tickers
ANVS
BIIB
Tags
ANVS
annovis Bio
News
From
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 03, 2021
Tickers
ACRX
ANVS
BLPH
CWBR
Tags
BLPH
MESO
Benzinga
From
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Tickers
ADPT
AFIB
ANVS
ATHX
Tags
AZN
PLXP
CMPI
From
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Tickers
ACHV
ACIU
AEMD
AGEN
Tags
MRK
BIIB
CCXI
From
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
DRNA
ENTA
OCUP
From
Benzinga
92 Biggest Movers From Friday
November 08, 2021
Tickers
AAOI
ABNB
ADGI
ADTX
Tags
THRX
CFLT
BIGC
From
Benzinga
44 Biggest Movers From Yesterday
October 15, 2021
Tickers
ALF
AMN
ANVS
AZYO
Tags
CRDL
Top Gainers
GRVI
From
Benzinga
3 Stocks Insiders Are Buying
October 14, 2021
Tickers
ANVS
LSCC
LTH
Tags
ANVS
Insider Buying
LSCC
From
Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
October 05, 2021
Tickers
ANVS
Tags
Phase 2 Trial
FDA
General
From
Benzinga
Here's How You Handle a Volatile Stock Like Cassava Sciences
September 02, 2021
Tickers
ANVS
INMB
SAVA
Tags
SAVA
ANVS
INMB
From
Motley Fool
Insiders Like Cassava Sciences, Which Might Be Good News
August 30, 2021
Tickers
ANVS
SAVA
Tags
NASDAQ:SAVA,NYSEAMERICAN:ANVS
Market News
SAVA
From
InvestorPlace
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
August 26, 2021
Tickers
ABBV
ALZN
AMRX
ANVS
Tags
Earnings
Small Cap
AVTE
From
Benzinga
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
August 26, 2021
Tickers
ANVS
BIIB
SAVA
Tags
Market News
ANVS
SAVA
From
Motley Fool
Tread Carefully Before Pulling the Trigger on Cassava Sciences
August 20, 2021
Tickers
ANVS
SAVA
Tags
Market News
NASDAQ:SAVA,NYSEAMERICAN:ANVS
ANVS
From
InvestorPlace
Why Might Cassava Succeed With Its Alzheimer's Drug, When So Many Have Failed?
August 14, 2021
Tickers
ANVS
BIIB
SAVA
Tags
Market News
BIIB
SAVA
From
Motley Fool
Why Is Biogen Pursuing a New Direction in Alzheimer's Research?
August 13, 2021
Tickers
ANVS
AVXL
BIIB
SAVA
Tags
BIIB
SAVA
ANVS
From
Motley Fool
Use Weakness in these 3 Alzheimer’s Disease Stocks as Opportunity
August 10, 2021
Tickers
ANVS
AVXL
SAVA
Tags
Market News
AVXL
NASDAQ:SAVA,NASDAQ:AVXL,NYSEAMERICAN:ANVS
From
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.